BCRX insider resale registers 62,500 shares

BCRX reported a Form 144 registering the resale of 62,500 shares of Common Stock for sale on 05/13/2026.

Rhea-AI Filing Summary

BCRX reported a Form 144 registering the resale of 62,500 shares of Common Stock for sale on 05/13/2026. The filing lists the sale method as cash and references an option granted 12/20/2017 as the source of the shares. The filing also records a prior sale of 150,000 shares on 03/16/2026 for $1,372,013.10.

Insights

Securities Compliance Counsel

Form 144 registers an insider resale of 62,500 shares tied to a 2017 option.

The filing lists 62,500 shares to be sold on 05/13/2026, sourced from an option granted 12/20/2017, with proceeds described as cash. This is a routine resale registration under transfer rules.

Prior activity in the excerpt shows a sale of 150,000 shares on 03/16/2026 for $1,372,013.10, which provides context about recent disposition activity. Cash‑flow treatment beyond 'cash' is not detailed in the excerpt.

Key Figures

Shares registered for resale: 62,500 shares Value listed: $596,250.00 Prior shares sold: 150,000 shares +1 more

4 metrics

Shares registered for resale 62,500 shares registered for sale on 05/13/2026

Value listed $596,250.00 amount appearing on the same line as 62,500 shares

Prior shares sold 150,000 shares sold on 03/16/2026 for $1,372,013.10

Outstanding/share context 254,162,660 number appearing in the excerpt with date 05/13/2026

Key Terms

Form 144, Option Granted - 12/20/2017, Securities To Be Sold

3 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Option Granted - 12/20/2017 financial

"Common | 05/13/2026 | Option Granted - 12/20/2017"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the BCRX Form 144 register?

The filing registers the resale of 62,500 shares of Common Stock for sale on 05/13/2026. It states the shares derive from an option granted 12/20/2017 and the method of sale is listed as cash.

Who is listed as the broker or holder in the BCRX Form 144?

The filing lists Fidelity Brokerage Services LLC with an address at 900 Salem Street, Smithfield, RI. The excerpt pairs this broker entry with the registered 62,500 shares scheduled for resale on 05/13/2026.

Has the reporting person sold shares recently for BCRX?

Yes. The excerpt records a prior sale of 150,000 shares on 03/16/2026 for $1,372,013.10. That transaction is shown separately from the current 62,500‑share resale registration.

Does the Form 144 disclose proceeds or use of proceeds for the registered sale?

The filing characterizes the sale method as cash, indicating a cash resale. The excerpt does not specify how proceeds will be used or who will receive them beyond the sale method description.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 01:06 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001584348
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BIOCRYST PHARMACEUTICALS INC
SEC File Number	000-23186
Address of Issuer	4505 EMPEROR BOULEVARD SUITE 200 DURHAM NORTH CAROLINA 27703
Phone	919-859-1302
Name of Person for Whose Account the Securities are To Be Sold	Barnes Alane P
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	62500	596250.00	254162660	05/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/13/2026	Option Granted - 12/20/2017	Issuer			62500	05/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Alane Barnes 4505 Emperor Blvd. Suite 200 Durham NC 27703	Common	03/16/2026	150000	1372013.10

144: Remarks and Signature

Remarks
Date of Notice	05/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Alane Barnes
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)